Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Supply Chain

I'rom Holdings Co Ltd

+ Add to Watchlist

2372:JP

2,080.0 JPY 11.0 0.53%

As of 01:00:00 ET on 01/28/2015.

Snapshot for I'rom Holdings Co Ltd (2372)

Open: 2,060.0 Day's Range: 2,060.0 - 2,135.0 Volume: 230,200
Previous Close: 2,069.0 52wk Range: 639.0 - 3,045.0 1-Yr Rtn: +118.49%

Stock Chart for 2372

No chart data available.
  • 2372:JP 2,081.0
  • 1D
  • 1M
  • 1Y
2,069.0
Interactive 2372 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2372

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -49.4600
Est. EPS (JPY) (03/2015) 0.0000
Est. PEG Ratio -
Market Cap (M JPY) 21,223.62
Shares Outstanding (M) 10.20
30 Day Average Volume 397,000
Price/Book (mrq) 5.1589
Price/Sale (ttm) 5.2881
Dividend Indicated Gross Yield -%
Cash Dividend (JPY) -
Dividend Ex-Date 03/29/2011
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2372

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2372

I'rom Holdings Co., Ltd. provides management services on clinical trials and staffing consulting services including providing nurses, pharmacists, and clinical pathologists to medical institutions as well as training medical- related staffs. The Company also provides and leases facilities and finances for these who are to start their clinics.

Toyotaka MroiPresidentHiroaki InukaiExecutive Vice President
Masaaki MatsushimaExecutive Vice PresidentChikaaki KatoDirector
More Company Profile & Key Executives for 2372

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • 2372 News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil